Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Guardant Health, Inc. | Director | Common Stock | 13.7K | $477K | $34.76 | Dec 15, 2024 | Direct |
Ginkgo Bioworks Holdings, Inc. | Director | Restricted Stock Units | 433K | $238K | $0.55 | Jun 13, 2024 | Direct |
Guardant Health, Inc. | Director | Restricted Stock Units | 684 | $23.8K | $34.76 | Dec 15, 2024 | Direct |
Ginkgo Bioworks Holdings, Inc. | Director | Stock Option | 571K | Jun 13, 2024 | Direct | ||
Guardant Health, Inc. | Director | Stock Option (Right to Buy) | 10.7K | Jun 12, 2024 | Direct | ||
Myovant Sciences Ltd. | Director | Common Shares | 0 | $27.00 | Mar 10, 2023 | Direct | |
Myovant Sciences Ltd. | Director | Stock Options (Right to Buy) | 0 | Mar 10, 2023 | Direct |